|
Loading...
| ||||||||||||||
Recent Publications by Merck Sharp & Dohme Research Laboratories: |  | |
| Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database.
INTRODUCTION: Sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, and... | Global Health Outcomes, Merck Sharp & Dohme Corp., One Merck | Adv Ther. 2010 Apr;27(4):223-32. Epub 2010 May 10.
DOI Direct Link |
| Asymmetric Hydrogenation of Protected Allylic Amines.
A general method for the enantioselective hydrogenation of protected... | Department of Process Research, Merck & Co. Inc., PO Box 2000, Rahway, New | Org Lett. 2010 Aug 24.
DOI Direct Link |
| Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies.
Rofecoxib (Vioxx(c) made by Merck Sharp & Dohme, the USA) is a... | Department of Histology and Embryology, Medical University of Lublin, 11 | Protoplasma. 2010 Aug 19.
DOI Direct Link |
| Effects of the renin inhibitor MK-8141 (ACT-077825) in patients with hypertension.
The renin inhibitor MK-8141 (ACT-077825) demonstrates substantial... | Merck Sharp and Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse | J Am Soc Hypertens. 2010 Aug 11.
DOI Direct Link |
| Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited.
In this report, the utility of a commonly used interspecies scaling method... | Department of Drug Metabolism and Pharmacokinetics, Merck Research | Biopharm Drug Dispos. 2010 May;31(4):253-63.
DOI Direct Link |